Drug recall · June 12, 2024
Tivicay PD recall
Why: Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37
- Lots / codes
Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025
- Quantity
- 463 Cartons
- Company
- GlaxoSmithKline LLC, Zebulon, NC
- Distribution
- Nationwide within the United States
- Initiated
- May 17, 2024 · Voluntary: Firm initiated
- Classified
- June 6, 2024
- Reported
- June 12, 2024
- Ended
- January 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tivicay
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.